ArticleAmerican journal of cancer research2026
Clinical effect evaluation of interventional embolization combined with pingyangmycin injection in the treatment of trunk and limbs Kaposi type hemangioendothelioma.
Article in American journal of cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the clinical efficacy of interventional embolization combined with Pingyangmycin injection in children with Kasai-type hemangioendothelioma (KHE).
methodsA retrospective analysis was conducted on 60 children with KHE admitted between January 2015 and December 2024. All patients were treated with interventional embolization combined with Pingyangmycin injection. Demographic and clinical data of patients were collected. The platelet count, coagulation function, therapeutic effect, and health-related quality of life (HRQoL) scores were compared before and after treatment. Survival outcomes were analyzed using Kaplan-Meier method. Factors affecting HRQoL were analyzed using univariate and multivariate regression analysis.
resultsThe total effective rate was 80%. The 1-year and 3-year survival rates were 93.3% and 66.67%, respectively. After treatment, the platelet count was significantly increased, and the coagulation function was significantly improved (P<0.05). In addition, the HRQoL scores of each dimension were significantly improved after treatment (P<0.01). Univariate and multivariate analysis identified activity disorder, platelet count, and parents' education level as independent factors affecting HRQoL (all P<0.05).
conclusionInterventional embolization combined with Pingyangmycin injection is an effective method for the treatment of KHE involving the trunk and limbs in children. It demonstrates good effects on correcting thrombocytopenia and improving the quality of life of affected children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.